Anton, S. F., Robinson, D. S., Roberts, D. L., Kensler, T. T., English, P. A., & Archibald, D. G. (1994). Long term treatment of depression with nefazadone. Psychopharmacology Bulletin, 30, 165-169.
2.
Cyr, M., & Brown, C. S. (1996). Nefazadone: Its place among the antidepressants. Annals of Pharmacotherapy, 30, 1006-1012.
3.
Lader, M. H. (1996). Tolerability and safety: Essentials in antidepressant pharmacotherapy. Journal of Clinical Psychiatry, 57(Suppl. 2), 39-44.
4.
Macleod, A. D. (1998). Methylphenidate in terminal depression. Journal of Pain and Symptom Management, 16, 193-198.
5.
Robinson, D. S., Marcus, R. N., Archibald, D. G., & Hardy, S. A. (1996). Therapeutic dose range of nefazadone in the treatment of major depression. Journal of Clinical Psychiatry, 57(Suppl. 2), 6-9.
6.
Robinson, D. S., & Roberts, D. L. (1996). Responders to antidepressant drug treatment: A study comparing nefazadone, imipramine and placebo in patients with major depression. Journal of Clinical Psychiatry, 57(Suppl.), 451-456.
7.
Schaller, J. L., & Behar, D. (1999). Treating comorbid ADHD, major depression and panic. Journal of Neuropsychiatry and Clinical Neuroscience, 11, 516.
8.
Srisurapanont, M. (1998). Response and discontinuation rates of newer antidepressants: A meta analysis of randomized controlled trials in treating depression. Journal of the Medical Association of Thailand, 81, 387-392.
9.
Zwicker, J., Bruck, D., Parkes, J. D., & Broughton, R. J. (1995). Acute mood improvement after dextroamphetamine and methylphenidate in narcolepsy. Journal of Sleep Research, 4, 252-255.
